Newsquawk Daily European Equity Opening News - 11th August 2026
European and global markets react to AstraZeneca's merger termination, Alcon's strong Q2 results, Santander's massive buyback, and Intel's heavily oversubscribed USD 20bln share sale amid health sector margin pressures.
News detail
ASIA APAC stocks traded mixed following a lacklustre lead from Wall Street, where risk sentiment was constrained by higher oil prices and yields amid geopolitical uncertainty, while conditions in Asia were thinned due to the Japanese holiday closure. ASX 200 gained amid strength in energy and miners following recent upside in underlying commodity prices, but with upside capped after weak NAB business confidence and heading into the RBA which kept rates unchanged as expected and maintained its hawkish tone, although it was slightly less hawkish, with the central bank acknowledging that financial conditions in Australia appear somewhat restrictive and it also trimmed CPI forecasts. KOSPI climbed alongside a rebound in tech and with notable gains in Samsung Electronics. Hang Seng and Shanghai Comp were lacklustre after the PBoC opted for zero liquidity operations today, although the downside in the mainland was cushioned following prior reports that China issued the first new round of consumption vouchers aimed at boosting spending. Hong Kong tax reforms - Authorities are reportedly considering changing proposed legislation to allow staff of prop trading firms to not incur tax on performance-related pay, the FT reports. This follows a bill introduced in June that aims to attract more funds and family offices to Hong Kong. (FT) EUROPEAN CLOSES CLOSES: Euro Stoxx 50 +0.15% at 6,534, Dax 40 +0.14% at 26,355, FTSE 100 -0.36% at 10,862, CAC 40 +0.13% at 8,726, FTSE MIB -0.10% at 53,664, IBEX 35 +0.03% at 20,183, PSI -0.29% at 9,155, SMI +0.50% at 14,617, AEX +0.17% at 1,113 FTSE 100 AstraZeneca (AZN LN), Bristol Myers Squibb (BMY) - The FT reports that a mostly share-based deal in which AstraZeneca would buy BMY at a premium had reached a serious stage, according to a source, and that the Cos were eyeing an announcement in mid-August. However, the report added, Astra's board issued the order to terminate talks after shares fell over 9% on August 3rd in the aftermath of the initial FT report detailing the potential merger. (FT) BP (BP / LN) - Co. is to sell 20% of its Cocuina gas field in Venezuela to Trinidad's National Gas Company, according to Reuters citing sources. The report adds that a final investment decision could come by the end of the year. (Reuters) Economy, Crypto - The heads of the crypto and digital assets all-party parliamentary group sent a letter to all British banks on Tuesday highlighting that the bank's refusal to provide services to crypto companies and investors risks being a barrier to growth in the UK's digital assets industry, the FT reports. (FT) Gambling, Smoking - The UK Government is to revoke an "outdated" provision within the Gambling Act that pushes councils towards approving new betting ships and 24-hour slot machine shops, giving local authorities stronger powers to block these shops from appearing on the streets. (FT) Glencore (GLEN LN) - A Glencore-backed consortium is looking to take control of Sherritt International, which operates North America's only significant cobalt refinery. (FT) Retail - UK BRC Retail Sales Monitor (Jul YY) 1.0% vs. Exp. 1.5% (Prev. 1.7%). OTHER UK COMPANIES BROKER MOVES BAE Systems (BA/ LN) initiated with Sector Perform at RBC Legal & General (LGEN LN) downgraded to Sell from Neutral at Goldman Sachs DAX Qiagen (QIA GY) - Co. announces the US FDA has cleared the QIAstat-Dx BCID GPF Plus AMR Panel. The panel detects 20 pathogen targets and 10 antimicrobial resistance markers from positive blood cultures in about one hour. (Qiagen) OTHER GERMAN COMPANIES Salzgitter (SZG GY) - H1 2026 (EUR): Group Revenue 4.59bln (prev. 4.66bln Y/Y), Group EBITDA 277.7mln (prev. 116.8mln Y/Y). Guides FY26 sales c. 10bln. (Salzgitter) TAG Immobilien (TEG GY) - H1 2026 (EUR): Rental Income 196.6mln (prev. 184.2mln Y/Y), Net Income 114.5mln (prev. 151.1mln Y/Y), FFO/shr 0.53 (prev. 0.52 Y/Y). Confirms FY26 outlook, now expects FFO 1 at the upper end of its guidance range. (TAG Immobilien) Shares indicated higher by 3.6% on Tradegate BROKER MOVES Carl Zeiss Meditec (AFX GY) downgraded to Sell from Neutral at UBS CAC LVMH (MC FP) - Louis Vuitton is looking for a liquor licence for the K11 KUSEA in Tsim Sha Tsui, Hong Kong, according to Dim Sum Daily. (Dim Sum Daily) OTHER FRENCH COMPANIES BROKER MOVES Thales (HO FP) initiated with Outperform at RBC PAN EUROPE Santander (SAN SM) - Co. announces a share buyback programme of EUR 1.825bln, set to begin August 24th. (Santander) BROKER MOVES SMI Alcon (ALC SW) - Q2 2026 (USD): Core EPS 0.84 (exp. 0.80), Revenue 2.78bln (prev. 2.58bln Y/Y). Raises its FY26 guidance, now sees core operating margin change between +90-190bps (prev. guided +70-170bps) and core diluted EPS growth between +12-15% (prev. guided +10-13%). (Alcon) US-listed ADR rose 3.5% after-hours OTHER SWISS COMPANIES Galderma (GALD SW)- Co. receives EU approval for its Restylane Shaype for temporary augmentation of the chin region. (Galderma) Tecan (TECN SW) - H1 2026 (CHF): Revenue 427.5mln (exp. 428.2mln), Adj. EBITDA 64.5mln (prev. 65.7mln Y/Y), Adj. EPS 2.62 (prev. 2.66 Y/Y). Confirms FY26 revenue and Adj. EBITDA margin guidance. (Tecan) BROKER MOVES SCANDINAVIA ISS AS (ISS DC) - H1 2026 (DKK): Revenue 44.7bln (exp. 44.1bln), Net Income 1.19bln (exp. 1.14bln), EBITDA 2.76bln (prev. 2.39bln Y/Y). Leaves FY26 guidance unchanged. Increases the second tranche of its share buyback by DKK 600mln, bringing the total programme to DKK 3.1mln. (ISS) Maersk (MAERSKB DC) - Co. says logistics operations in parts of Colombia are currently facing disruptions following the earthquake. Terminal operations in Buenaventura have been temporarily suspended while facility and infrastructure assessments are underway. (Maersk) YIT OYJ (YIT FH) - Co. has signed a contract with a laser technology company, Light Conversion, for the development and construction of a new manufacturing facility in Vilnius, Lithuania. (YIT) BROKER MOVES Outokumpu (OUT1V FH) upgraded to Overweight from Neutral at JPMorgan, citing the Co.'s high leverage to a European stainless earnings recovery and relatively cheaper valuation. US CLOSES: SPX -0.05% at 7,753, NDX -0.34% at 26,622, DJI -0.11% at 53,976, RUT -0.50% at 3,019. SECTORS: Energy +4.63%, Health +1.66%, Communication Services +0.68%, Materials +0.68%, Financials +0.32%, Consumer Discretionary +0.27%, Consumer Staples -0.22%, Industrials -0.30%, Technology -1.10%, Utilities -1.11%, Real Estate -1.23%. Hims & Hers Health (HIMS) - Shares fell almost 7% in extended trading after a much wider-than-expected quarterly loss and pressure on margins from its shift towards branded weight-loss drugs and international expansion outweighed a raised revenue outlook. It reported Q2 EPS -0.37 (exp. -0.01), Q2 adj. EBITDA USD 60.3mln (vs 82.2mln Y/Y), Q2 revenue USD 753mln (exp. 730.1mln); Q2 subscribers 2.9mln (exp. 2.74mln). CEO said customer relationships and global scale continue to deepen despite lower Y/Y adj. EBITDA. Sees Q3 revenue between USD 880-900mln (exp. 862.7mln); sees FY26 revenue between USD 3.1-3.3bln (exp. 3.05bln), FY26 adj. EBITDA between USD 275-325mln, implying an adjusted EBITDA margin between 9-10%. Intel (INTC) - Intel sought to increase its share sale to about USD 20bln with an over-allotment option (from an initially touted USD 15bln), Bloomberg reports; the offering has reportedly attracted more than USD 100bln in demand. Pricing is expected around USD 95/shr+ (vs closing price of USD 97.52/shr on Monday).
Related stocks
9 stocksWhat do investors think?
StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
